WallStreetZenWallStreetZen

NYSE: ENFN
Enfusion Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ENFN

Based on 4 analysts offering 12 month price targets for Enfusion Inc.
Min Forecast
$9.00-0.88%
Avg Forecast
$10.25+12.89%
Max Forecast
$11.00+21.15%

Should I buy or sell ENFN stock?

Based on 4 analysts offering ratings for Enfusion Inc.
Buy
Strong Buy
1 analysts 25%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENFN stock forecasts and price targets.

ENFN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Bottom 25%
25
HoldMaintains$10.00+10.13%2023-08-09
Morgan Stanley
Top 27%
74
Strong BuyMaintains$11.00+21.15%2023-08-09
Piper Sandler
Top 7%
94
HoldMaintains$9.00-0.88%2023-05-22
Credit Suisse
Bottom 5%
5
HoldMaintains$11.00+21.15%2023-05-10

1 of 1

Forecast return on equity

Is ENFN forecast to generate an efficient return?
Company
-12.82%
Industry
-56.43%
Market
48.79%
ENFN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENFN forecast to generate an efficient return on assets?
Company
-6.56%
Industry
3.48%
ENFN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENFN revenue growth forecast

How is ENFN forecast to perform vs Software - Application companies and vs the US market?
Company
18.8%
Industry
8.98%
Market
12.08%
ENFN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ENFN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ENFN vs App Stocks

TickerPricePrice TargetUp/downsideConsensus
ENFN$9.08$10.25+12.89%Buy
KC$4.76$5.00+5.04%Hold
PAR$41.13$41.50+0.90%Buy
WALD$10.20N/AN/A
AVID$26.84$27.03+0.69%Hold
View Top App Stocks

Enfusion Stock Forecast FAQ

Is Enfusion Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ENFN) stock is to Buy ENFN stock.

Out of 4 analysts, 1 (25%) are recommending ENFN as a Strong Buy, 0 (0%) are recommending ENFN as a Buy, 3 (75%) are recommending ENFN as a Hold, 0 (0%) are recommending ENFN as a Sell, and 0 (0%) are recommending ENFN as a Strong Sell.

If you're new to stock investing, here's how to buy Enfusion stock.

What is ENFN's forecast return on equity (ROE) for 2023-2024?

(NYSE: ENFN) forecast ROE is -12.82%, which is considered weak.

What is ENFN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ENFN price target, the average ENFN price target is $10.25, with the highest ENFN stock price forecast at $11.00 and the lowest ENFN stock price forecast at $9.00.

On average, Wall Street analysts predict that Enfusion's share price could reach $10.25 by Aug 9, 2024. The average Enfusion stock price prediction forecasts a potential upside of 12.89% from the current ENFN share price of $9.08.

What is ENFN's forecast return on assets (ROA) for 2023-2024?

(NYSE: ENFN) forecast ROA is -6.56%, which is lower than the forecast US Software - Application industry average of 3.48%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.